Litigation Details for VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. MYLAN PHARAMACEUTICALS, INC. (D.N.J. 2017)
✉ Email this page to a colleague
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. MYLAN PHARAMACEUTICALS, INC. (D.N.J. 2017)
| Docket | ⤷ Start Trial | Date Filed | 2017-09-01 |
| Court | District Court, D. New Jersey | Date Terminated | 2018-06-04 |
| Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Cathy L. Waldor |
| Parties | MYLAN INC. | ||
| Patents | 8,247,425; 8,420,663; 8,552,025; 8,822,490; 9,180,125; 9,492,445; 9,669,096 | ||
| Attorneys | JASON B. LATTIMORE | ||
| Firms | Law Office of Jason B. Lattimore, Esq. | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. MYLAN PHARAMACEUTICALS, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Start Trial .
Details for VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. MYLAN PHARAMACEUTICALS, INC. (D.N.J. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-09-01 | External link to document | |||
| 2017-09-01 | 11 | inter alia, the ’096 patent, the ’445 patent, and U.S. Patent Nos. 8,247,425, 8,420,663, 8,552,025, …“the Orange Book”), together with U.S. Patent Nos. 8,247,425, 8,420,663, 8,552,025, 8,822,490, and 9,…against Defendants with respect to U.S. Patent Nos. 8,247,425, 8,420,663, 8,552,025, 8,822,490, and …United States Patent Nos. 9,669,096 (“the ’096 patent”) and 9,492,445 (“the ’445 patent”) arising under…United States Patent Nos. 9,669,096 (“the ’096 patent”) and 9,492,445 (“the ’445 patent”) arising under | External link to document | |
| 2017-09-01 | 32 | Stipulation and Order | x27; U.S. Patent No. 9,669,096 (“'096 Patent”) and U.S. Patent No. 9,492,445 (“’445 Patent”) asserted…’096 Patent and ’445 Patent in any future litigation over the ’096 Patent and/or the ’445 Patent pertaining…l£ag%ez2 op4lba §?:§\B|DZBZSS the ’096 Patent and ’445 Patent would be infringed by any unlicensed manufacturel…be enjoined until expiration of the ’096 Patent and ’445 Patent from (i) making, using, offering to sell… importing until expiration of the ’096 Patent and ’445 Patent the Actavis Products in the United States | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
